Nava Raj Sharma

Dr. Nava Raj Sharma

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2024 in Clinical Case Reports
Verified
Journal Article
Open access
ABArjun Basnet
Arjun Basnet
NSNava Raj Sharma
Nava Raj Sharma
SGSudarshan Gautam
Sudarshan Gautam
SLSaral Lamichhane
Saral Lamichhane
SKSajog Kansakar
Sajog Kansakar
SSSehajpreet Singh
Sehajpreet Singh
Key Clinical Message: Immune checkpoint inhibitors can rarely lead to occurrence of myositis, myocarditis, and myasthenia gravis (MG). Early recognition and multidisciplinary management are crucial for optimal outcomes. Vigilance for overlapping toxicities is essential in patients receiving combination immunotherapy. The use of immune checkpoint inhibitors (ICIs) has revolutionized cancer treatment, but it is associated with immune‐related adverse events (IRAEs) affecting various organ systems. The simultaneous occurrence of MG, myocarditis, and myositis highlights the complex nature of IRAEs. Early recognition and comprehensive multidisciplinary management are crucial for optimal patient outcomes. We present a unique case report of a 76‐year‐old male patient with advanced melanoma who developed concurrent myositis, myocarditis, and MG while receiving combination immunotherapy with Nivolumab and Ipilimumab. This case underscores the significance of recognizing and addressing the “Terrible Triad” of IRAEs in patients receiving ICIs. Healthcare providers should maintain a high index of suspicion for overlapping toxicities and promptly initiate appropriate interventions.

10 July 2024 in Cureus
Verified
Journal Article
Open access
PDF file
MBMarlon E. Rivera Boadla
Marlon E. Rivera Boadla
NSNava Raj Sharma
Nava Raj Sharma
JVJeffy Varghese
Jeffy Varghese
SLSaral Lamichhane
Saral Lamichhane
MKMuhammad H. Khan
Muhammad H. Khan
ASAnupam Sharma
Anupam Sharma
Cardiovascular disease remains a leading global health challenge, necessitating advanced diagnostic approaches. This review explores the integration of artificial intelligence (AI) in multimodal cardiac imaging, tracing its evolution from early X-rays to contemporary techniques such as CT, MRI, and nuclear imaging. AI, particularly machine learning and deep learning, significantly enhances cardiac diagnostics by estimating biological heart age, predicting disease risk, and optimizing heart failure management through adaptive algorithms without explicit programming or feature engineering. Key contributions include AI's transformative role in non-invasive coronary artery disease diagnosis, arrhythmia detection via wearable devices, and personalized treatment strategies. Despite substantial progress, challenges including data standardization, algorithm validation, regulatory approval, and ethical considerations must be addressed to fully harness AI's potential. Collaborative efforts among clinicians, scientists, industry stakeholders, and regulatory bodies are essential for the safe and effective deployment of AI in cardiac imaging, promising enhanced diagnostics and personalized patient care.

7 June 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SGSudarshan Gautam
Sudarshan Gautam
NSNava Raj Sharma
Nava Raj Sharma
SKSajog Kansakar
Sajog Kansakar
SLSaral Mbbs Lamichhane
Saral Mbbs Lamichhane
MPMadalasa Pokhrel
Madalasa Pokhrel
ABArjun Basnet
Arjun Basnet
Introduction and importance: Infective endocarditis (IE) primarily affects the endocardium of heart valves. Neurologic manifestations include strokes, intracerebral hemorrhages, meningitis, cerebral and spinal abscess, and mycotic aneurysms. Although rare, meningitis is a potentially life-threatening complication of IE, so physicians should be aware of this rare and fatal complication of IE. Case presentation: Here, the authors present a case of a 53-year-old male who presented with bacterial meningitis secondary to IE. His blood culture was positive for methicillin-sensitive staphylococcal aureus. Echocardiography findings were suggestive of endocarditis. Despite aggressive intensive care management, our patient did not survive. Clinical discussion: The isolation of Staphylococcus aureus in culture should raise a suspicion of foci being elsewhere outside the central nervous system. Treatment of complications like meningitis may require intrathecal antibiotics. The vegetation and neurological complications are often difficult to treat and require the participation of a multidisciplinary team. Conclusions: The diagnosis of IE in patients presenting with neurologic deficits and fever should be considered. A physician should raise a suspicion of infective foci being elsewhere outside the central nervous system if the organism isolated in culture is Staphylococcus aureus.

24 May 2024 in Clinical Case Reports
Verified
Journal Article
Open access
NSNava Raj Sharma
Nava Raj Sharma
ABArjun Basnet
Arjun Basnet
SLSaral Lamichhane
Saral Lamichhane
KTKripa Tiwari
Kripa Tiwari
JVJeffy Varghese
Jeffy Varghese
MPMadalasa Pokhrel
Madalasa Pokhrel
Key Clinical Message: Chronic ketamine use can lead to sphincter of oddi dysfunction (SOD), causing various hepatobiliary complications. Recognizing substance abuse history is vital for early detection. Timely intervention can prevent irreversible liver and pancreas damage. Ketamine is commonly abused as a recreational drug worldwide due to its ability to induce euphoria‐like effects. Ketamine abuse is associated with many hepatobiliary side effects ranging from cholestasis to biliary sepsis and death. Here we present a case of a young 29‐year female with upper abdominal pain due to SOD resulting from chronic use of ketamine. SOD can result in obstruction or dysfunction of the bile and pancreatic ducts. Ketamine induces SOD by activation of the muscarinic receptors in the sphincter of oddi. Detail history of substance abuse is crucial for early identification of ketamine‐induced SOD. Early identification and treatment of this rare condition can prevent permanent injury to the liver and pancreas.

13 September 2022 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SLSaral Lamichhane
Saral Lamichhane
NSNava Raj Sharma
Nava Raj Sharma
MPMadalasa Pokhrel
Madalasa Pokhrel
BPBishal Panthi
Bishal Panthi
MBManoj Bist
Manoj Bist
Rheumatic heart disease results from the damage to heart valves caused by one or more episodes of rheumatic fever leading to a variety of cardiac complications. Although less common in developed parts of the world, it is one of the most common acquired heart diseases in low-and middle-income countries including Nepal, affecting children and young people. Primary prevention with prompt treatment of streptococcal throat infections and long-term secondary antibiotic prophylaxis with benzathine penicillin G are the key intervention strategies. Echocardiography based screening in schoolchildren has become an effective measure for early identification of the cases. More coordinated policies and effective interventions are needed to successfully decrease the burden of the rheumatic heart disease in resource limited settings like Nepal.

7 August 2023 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
NSNava Raj Sharma
Nava Raj Sharma
AWAbhishesh Wagle
Abhishesh Wagle
MBManoj Mbbs Bist
Manoj Mbbs Bist
BPBishal Mbbs Panthi
Bishal Mbbs Panthi
RDRitu Pokhrel Dahal
Ritu Pokhrel Dahal
MPMadalasa Pokhrel
Madalasa Pokhrel
Introduction and importance: While 14-day triple therapy with clarithromycin is a common approach for eradicating Helicobacter pylori infection, it is essential to note that this treatment does not come without potential side effects. Case presentation: We present the case of a 34-year-old male who presented to the emergency department with severe vomiting and abdominal pain. Subsequent evaluation revealed that the patient had developed drug-induced liver injury (DILI). Clinical discussion: DILI can cause acute hepatocellular or cholestatic damage, and chronic injury can lead to hepatocellular, cholestatic, vascular, or neoplastic manifestations. Conclusion: Clinicians should exercise caution and be alert to the potential hepatotoxic effects of medications, especially when initiating triple therapy for H. pylori infection.